ElevateBio logo

ElevateBio Funding & Investors

Cambridge, MA

ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.

elevate.bio

Total Amount Raised: $1,246,000,000

ElevateBio Funding Rounds

  • Series D

    $401,000,000

    Series D Investors

    Matrix Capital Management
    Redmile Group
    MPM Capital
    SVF
    F2 Ventures
    Woodline Partners
    Invus
    Novo Nordisk
    Fidelity
    Emerson Collective
    Surveyor Capital
    EcoR1 Capital
    Samsara BioCapital
    Vertex Ventures
    EDBI
    ITOCHU
  • Series C

    $525,000,000

    Series C Investors

    Matrix Capital Management
    EcoR1 Capital
    MPM Capital
    SVF
    F2 Ventures
    Invus
    Fidelity
    Vertex Ventures
    Redmile Group
    ITOCHU
    Surveyor Capital
    Samsara BioCapital
    Emerson Collective
    EDBI
  • Series B

    $170,000,000

    Series B Investors

    EDBI
    Samsara BioCapital
    Invus
    F2 Ventures
    Redmile Group
    MPM Capital
    EcoR1 Capital
    Vertex Ventures
    Surveyor Capital
  • Series A

    $150,000,000

    Series A Investors

    UBS Oncology Impact Fund
    Redmile Group
    Samsara BioCapital
    EcoR1 Capital
Funding info provided by Diffbot.